Microbot Medical Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Microbot Medical Inc. on July 28, 2025, covering events occurring since July 17, 2025. The company is incorporated in Delaware and its common stock trades on the NASDAQ Capital Market under the symbol "MBOT."
Key Financial Metrics
The filing reports a specific capital raise event rather than periodic financial performance metrics.
- Gross Proceeds: Approximately $4.2 million generated from the exercise of Series G preferred investment options.
- Shares Issued: 2,395,715 shares of common stock.
- Exercise Price: $1.75 per share.
- Revenue, Profit, Cash Flow, Debt, and Margins: The filing text does not provide a clear value for these metrics.
Material Changes
The primary material change is the issuance of 2,395,715 shares of common stock upon the exercise of outstanding Series G Options. These shares were issued pursuant to the Section 4(a)(2) exemption under the Securities Act of 1933. The shares are registered for resale on Form S-3 (Registration No.: 333-284688).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the description of the unregistered sale of equity securities.
Investor Verification Checklist
- Verify the final net proceeds after deducting placement agent fees and expenses.
- Confirm the updated total share count and potential dilution impact.
- Review the Form S-3 (Registration No.: 333-284688) for resale restrictions on the newly issued shares.
- Check subsequent filings for the impact of the $4.2 million cash infusion on the company's liquidity position.